CD274 and esophageal cancer: For example, the DNMTi 5-aza-2′-deoxycytidine combined with the antitumor effects of PD-1/PD-L1 provides a more effective immune response and clinical benefit for patients with esophageal cancer (Wu Y et al., 2020).